Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

Completed

Conditions studied: Type 1 Diabetes, Type 2 Diabetes

In brief

The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.

Key facts

Study ID

NCT01415115

Run by

VeraLight, Inc.

People needed

250

Starts

2007-03-01

Expected to finish

2011-08-01

Last updated by the study team

2011-08-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Potential subjects for the study will have type 1 or type 2 diabetes. Patients presenting for their periodic examinations at his practice will be given the opportunity to participate. Enrollment will conclude when the target of 250 subjects have been examined.

You may not qualify if…

• Wounds or injuries on the volar forearm in the field of view of SCOUT including blisters, cuts, scabs, cracked skin, tattoos and bleeding or oozing skin
• Rash on forearm in field of SCOUT scan including eczema, psoriasis, shingles, rosacea, swimmer's itch, Christmas tree rash, lichen planus, contact dermatitus, ringworm, heat rash or drug rash
• Receiving other investigational treatments
• Receiving medications that may alter skin fluorescence/photosensitivity, including Doxorubicin, Daunomycin, Camptothecin, Protoporphyrin, Fluoroquinolones, Tetracycline and/or Quinidine
• Known to be pregnant
• Prisoner, mentally incompetent or unable to follow study procedures

Where it is running

• Medstar Health Research Institute — Hyattsville, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.